ClinicalTrials.gg

Program

sildenafil

Also written as “Sildenafil”, “Sildenafil citrate” and “sildenafil citrate”.

Its studies are mostly in Erectile Dysfunction · Pulmonary Arterial Hypertension · Hypertension, Pulmonary · Sexual Dysfunctions, Psychological · Persistent Fetal Circulation Syndrome, led by 10 companies.

Furthest: phase 4, since Aug 26, 200560 company-led studies, 0 open or running

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Viatris470 open or runningphase 4since Aug 26, 2005Aug 26, 2005none ahead
Strategic Science & Technologies40 open or runningphase 2since Mar 9, 2015Oct 29, 2013none ahead
Hanmi Pharmaceutical20 open or runningphase 3since Jul 30, 2013Jan 18, 2012none ahead
Daré Bioscience10 open or runningphase 1since Mar 1, 2023Mar 1, 2023none ahead
emotional-brain-ny-inc10 open or runningphase 2since Aug 17, 2011Aug 17, 2011none ahead
Hamad Medical10 open or runningphase 3since Mar 11, 2012Mar 11, 2012none ahead
Hoffmann-La Roche10 open or runningphase 2since Oct 28, 2016Oct 28, 2016none ahead
laborato-rio-teuto-brasileiro-s-a10 open or runningphase 3since Mar 15, 2011Mar 15, 2011none ahead
n4-pharma-uk-ltd10 open or runningphase 1since Apr 12, 2018Apr 12, 2018none ahead
Pharmtechnology10 open or runningphase 1since May 6, 2021May 6, 2021none ahead

Also a collaborator on its studies: Pfizer, bdd-pharma-ltd and icos-corporation.

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

Before these, 45 studies since Aug 26, 2005.

  1. Mar 11, 2012Hamad Medical's first study: phase 3 study in Persistent Fetal Circulation SyndromeNew to Hamad MedicalHamad Medical · NCT01558466 · 100 enrolled · Qatar
  2. Jun 15, 2012Phase 4 study in Pulmonary Arterial HypertensionViatris · NCT01642407 · 6 enrolled · Japan
  3. Aug 1, 20122 phase 1 studies in HealthyViatris · NCT01656798, NCT01737203
  4. Sep 17, 2012Phase 3 study in Persistent Fetal Circulation SyndromeViatris · NCT01720524 · 59 enrolled · United States, Belgium, Canada and more
  5. Jul 30, 2013Phase 3 study in Hypertension, PulmonaryHanmi Pharmaceutical · NCT01913847 · 144 enrolled · Korea, Republic of
  6. Oct 29, 2013Strategic Science & Technologies's first study: phase 1 study in HealthyNew to Strategic Science & TechnologiesStrategic Science & Technologies · NCT01986673 · 62 enrolled · United States
  7. Jan 29, 2014Phase 4 study in Pulmonary Arterial HypertensionViatris · NCT02060487 · 385 enrolled · United States, Australia, Belgium and more
  8. Jan 27, 2015Phase 1 study in Female Sexual HealthStrategic Science & Technologies · NCT02364882 · 21 enrolled · United States
  9. Mar 9, 2015Phase 2 study in Erectile DysfunctionStrategic Science & Technologies · NCT02390960 · 33 enrolled · United States
  10. Oct 28, 2016Hoffmann-La Roche's first study: phase 2 study in Idiopathic Pulmonary FibrosisNew to Hoffmann-La RocheHoffmann-La Roche · NCT02951429 · 177 enrolled · Belgium, Canada, Czechia and more
  11. Apr 12, 2018n4-pharma-uk-ltd's first study: phase 1 study in Erectile DysfunctionNew to n4-pharma-uk-ltdn4-pharma-uk-ltd · NCT03510338 · 12 enrolled · United Kingdom
  12. May 6, 2021Pharmtechnology's first study: phase 1 study in BioequivalenceNew to PharmtechnologyPharmtechnology · NCT04882826 · 44 enrolled · Russian Federation
  13. Jun 24, 2021Phase 2 study in Sexual Dysfunction, PhysiologicalStrategic Science & Technologies · NCT04948151 · 440 enrolled · United States
  14. Mar 1, 2023Daré Bioscience's first study: phase 1 study in Sexual Dysfunctions, PsychologicalNew to Daré BioscienceDaré Bioscience · NCT05765487 · 13 enrolled · Canada

TargetBeta

PDE5A →read by rule
“Phosphodiesterase 5A inhibitor”ChEMBL 37, by rule

Other programs on PDE5A

ProgramCompanyFurthest phaseStudies
TadalafilruleEli Lillyphase 473

Studies

All 60 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusLed byPrimary completionSize
NCT05765487Sexual Dysfunctions, Psychological · Canada1CompletedDaré BioscienceJan 26, 202413
NCT04948151Sexual Dysfunction, Physiological · United States2UNKNOWNStrategic Science & TechnologiesDec 15, 2021440
NCT04882826Bioequivalence · Russian Federation1UNKNOWNPharmtechnologyMay 30, 202144
NCT03510338Erectile Dysfunction · United Kingdom1Completedn4-pharma-uk-ltdJun 13, 201812
NCT02951429Idiopathic Pulmonary Fibrosis · Belgium, Canada, Czechia and more2CompletedHoffmann-La RocheSep 26, 2019177
NCT02390960Erectile Dysfunction · United States2CompletedStrategic Science & TechnologiesApr 201733
NCT02364882Female Sexual Health · United States1CompletedStrategic Science & TechnologiesMay 201521
NCT02060487Pulmonary Arterial Hypertension · United States, Australia, Belgium and more4TerminatedViatrisFeb 26, 2021385
NCT01986673Healthy · United States1CompletedStrategic Science & TechnologiesNov 201362
NCT01913847Hypertension, Pulmonary · Korea, Republic of3UNKNOWNHanmi PharmaceuticalDec 2018144
NCT01720524Persistent Fetal Circulation Syndrome · United States, Belgium, Canada and more3CompletedViatrisOct 17, 201859
NCT01737203Healthy · Japan1CompletedViatrisSep 201253
NCT01656798Healthy · Singapore1CompletedViatrisAug 201212
NCT01642407Pulmonary Arterial Hypertension · Japan4CompletedViatrisMay 20, 20166
NCT01558466Persistent Fetal Circulation Syndrome · Qatar3UNKNOWNHamad MedicalNov 2014100
NCT01514903Erectile Dysfunction · Korea, Republic of1CompletedHanmi PharmaceuticalDec 201154
NCT01432665Sexual Dysfunctions, Psychological · United States2Completedemotional-brain-ny-incMay 2013196
NCT01360671Persistent Fetal Circulation Syndrome2WithdrawnViatrisApr 20130
NCT01321489Erectile Dysfunction · Brazil3UNKNOWNlaborato-rio-teuto-brasileiro-s-aJan 201278
NCT01247805Pulmonary Arterial Hypertention · Belgium1CompletedViatrisFeb 201142
NCT01254396Erectile Dysfunction · Singapore1CompletedViatrisJan 201112
NCT01254383Erectile Dysfunction · Singapore1CompletedViatrisMar 201136
NCT01027117Healthy · Belgium1CompletedViatrisSep 200918
NCT00904748Erectile Dysfunction · Brazil1CompletedViatrisMar 201047
NCT00866463Erectile Dysfunction · United States1CompletedViatrisOct 200818
NCT00800592Hypertension, Pulmonary · Belgium1CompletedViatrisDec 200812
NCT00795938Erectile Dysfunction · United States1CompletedViatrisNov 200818
NCT00746967Sexual Dysfunctions, Psychological · United States2CompletedViatris267
NCT00654082Spinal Cord Injuries · Turkey4CompletedViatris88
NCT00654017Erectile Disfunction · Brazil4CompletedViatris100
NCT00648596Erectile Dysfunction · Finland, France, Italy and more4CompletedViatris780
NCT00644956Erectile Dysfunction · Norway, United Kingdom4CompletedViatris56
NCT00644631Erectile Dysfunction · United States4CompletedViatris300
NCT00645268Erectile Dysfunction · United States, Canada4CompletedViatris300
NCT00645034Prostatic Hyperplasia · United States2CompletedViatris20
NCT00644605Hypertension, Pulmonary · United States, Australia, Belgium and more3CompletedViatris275
NCT00640458Female Sexual Arousal Disorder · United States, Australia2CompletedViatris20
NCT00468650Erectile Dysfunction · Mexico4CompletedViatrisFeb 2008117
NCT00454207Hypertension, Pulmonary · Japan3CompletedViatrisFeb 200944
NCT00430716Pulmonary Arterial Hypertension · United States, Belgium, Brazil and more4TerminatedViatrisMay 25, 2010130
NCT00343200Erectile Dysfunction · United States4CompletedViatris371
NCT00323297Pulmonary Arterial Hypertension · United States, Australia, Czechia and more4CompletedViatrisAug 2013105
NCT00301262Erectile Dysfunction · Canada4CompletedViatrisSep 2007183
NCT00249730Erectile Dysfunction · Canada, France, Greece and more4CompletedViatris510
NCT00245596Erectile Dysfunction · France4CompletedViatris120
NCT00245258Erectile Dysfunction · Korea, Republic of, Russian Federation, Spain and more4CompletedViatris312
NCT00159913Pulmonary Arterial Hypertension · United States, Brazil, Canada and more3CompletedViatrisJun 2008235
NCT00159900Erectile Dysfunction · Brazil, Germany, Italy and more4CompletedViatris300
NCT00159887Hypertension, Pulmonary · United States, Australia, Belgium and more3CompletedViatris260
NCT00159874Pulmonary Arterial Hypertension · United States, Brazil, Chile and more3CompletedViatrisDec 2012234
NCT00159861Hypertension, Pulmonary · United States, Belgium, Canada and more3CompletedViatris267
NCT00159809Erectile Dysfunction4CompletedViatris140
NCT00151463Erectile Dysfunction · Australia4CompletedViatris100
NCT00150358Erectile Dysfunction · Mexico4CompletedViatris253
NCT00147628Erectile Dysfunction · United States4CompletedViatris209
NCT00145483Meniere Disease · Australia4CompletedViatrisNov 8, 2006163
NCT00143260Erectile Dysfunction · United States4CompletedViatrisMay 2006250
NCT00143221Erectile Dysfunction4CompletedViatris350
NCT00141310Pre-Eclampsia · United Kingdom2TerminatedViatris76
NCT00137072Erectile Dysfunction · United States4CompletedViatris355

How it is read

Names in the registry

  • “Sildenafil”, 27 entries
  • “sildenafil”, 18 entries
  • “Sildenafil citrate”, 14 entries
  • “sildenafil citrate”, 10 entries
  • “Sildenafil Citrate”, 4 entries

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.